BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.40 -0.01 (-0.29%)
As of: Oct 23, 2026 · 2:05 PM EDT

BriaCell Therapeutics (BCTX) Cash & Current Investments (2019 - 2026)

Updated

BriaCell Therapeutics (BCTX) reported Cash & Current Investments of $22.8 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 83.0% from $12.46 million a year earlier but down 23.7% from the prior quarter.

Analysis

BriaCell Therapeutics (BCTX) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Jul 31, 2025), BriaCell Therapeutics posted Cash & Current Investments of $17.87 million.

  • Cash & Current Investments has a five-year compound annual growth rate of 291.5% (FY2020 to FY2025).
  • By fiscal year, Cash & Current Investments came in at $862,089 in FY2024 (-95.9%), $21.25 million in FY2023 (-48.2%), $41.04 million in FY2022 (-28.3%) and $57.27 million in FY2021.
  • Five-year quarterly Cash & Current Investments spans a low of $862,089 in fiscal Q4 2024 and a high of $57.27 million in fiscal Q4 2021.
  • Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 80.3% over the last six quarters.
  • The high point for year-over-year Cash & Current Investments in five years was fiscal Q2 2026 (growth of 496.4%); the low point was fiscal Q3 2024 (a decline of 96.7%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $29.9 million (Q2 2026), $10.18 million (Q1 2026) and $17.87 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,129.53 Bn 1,098.12 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 634.39 Bn 554.25 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn 6.57 Bn
4 Merck 358.13 Bn 312.50 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 289.84 Bn 253.83 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.39 Bn 239.08 Bn 12.86 Bn 4.90 Bn
7 Amgen 238.10 Bn 193.50 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.55 Bn 168.75 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn 11.70 Bn
10 BriaCell Therapeutics 24.65 Mn -56.10 Mn - 22.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 22.80 Mn
Jan 31, 2026 29.90 Mn
Oct 31, 2025 10.18 Mn
Jul 31, 2025 17.87 Mn
Apr 30, 2025 12.46 Mn
Jan 31, 2025 5.01 Mn
Oct 31, 2024 5.79 Mn
Jul 31, 2024 862,089.00
Apr 30, 2024 935,694.00
Jan 31, 2024 6.24 Mn
Oct 31, 2023 13.65 Mn
Jul 31, 2023 21.25 Mn
Apr 30, 2023 28.17 Mn
Jan 31, 2023 33.50 Mn
Oct 31, 2022 37.45 Mn
Jul 31, 2022 41.04 Mn
Apr 30, 2022 44.53 Mn
Jan 31, 2022 47.98 Mn
Jul 31, 2021 57.27 Mn
Apr 30, 2021 20.06 Mn
API Access

BriaCell Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BCTX&period=max&api_key=YOUR_API_KEY